Tandem Diabetes (TNDM) Care Announces FDA Clearance of Control-IQ+ Automated Insulin Delivery Technology for People with Type 2 Diabetes

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. DFTX
7. GOOGL
8. MU
9. IBM
10. HOOD

Go back to Tandem Diabetes (TNDM) Care Announces FDA Clearance of Control-IQ+ Automated Insulin Delivery Technology for People with Type 2 Diabetes

Tandem Diabetes Care (TNDM) PT Lowered to $35 at Citi

February 27, 2025 5:42 AM EST

Citi analyst Joanna Wuensch lowered the price target on Tandem Diabetes Care (NASDAQ: TNDM) to $35.00 (from $50.00) while maintaining a Buy rating.

The analyst comments "Tandem delivered 4Q24 revenue that was modestly higher than expectations, delivering $252.4M (up 20.6%) ahead of consensuss $249.7M,... More